Initial quality control evaluations for susceptibility testing of Dalbavancin (BI397), an investigational glycopeptide with potent gram-positive activity.
about
Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using gram-positive organisms.Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United StatesDalbavancin: an investigational glycopeptide.Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent.Antipneumococcal activity of dalbavancin compared to other agents.Dalbavancin Activity When Tested against Streptococcus pneumoniae Isolated in Medical Centers on Six Continents (2011 to 2014).A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically.Antistaphylococcal activity of dalbavancin, an experimental glycopeptide.Bactericidal activity and resistance development profiling of dalbavancin.Meningitis due to vancomycin-resistant Enterococcus faecium successfully treated with combined intravenous and intraventricular chloramphenicol.Revised reference broth microdilution method for testing telavancin: effect on MIC results and correlation with other testing methodologies.Effect of polysorbate 80 on oritavancin binding to plastic surfaces: implications for susceptibility testing.
P2860
Q35073036-10E0D693-DC12-4D22-B460-79A4AD211D71Q35690571-EE79DB5D-2F54-49A2-97C5-DF685903D314Q35964740-BDDFE374-649E-492C-99EE-47FCF5573D2EQ36098775-65C887EC-D474-4554-9E30-8C694C81E752Q40668272-D3DFBB61-68CB-4510-9638-D6DEA0D6FE36Q40746046-1FA75373-D087-40F4-8B88-6C4F458D7799Q40993969-C9942A77-8593-420C-824D-A23A7AF09476Q41005410-01FCFFF8-639E-4852-957B-0CE4E2F3730EQ41839607-C4FA9F72-A425-4079-88BA-774DB4DD5ECBQ42593900-80708668-FDB3-4363-8952-66082F9AA3C2Q42797044-57AA7516-B74E-459D-8722-C8CDF2A1EE52Q43183372-9A05ADDE-159D-477C-86FC-68C081DDDB5C
P2860
Initial quality control evaluations for susceptibility testing of Dalbavancin (BI397), an investigational glycopeptide with potent gram-positive activity.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Initial quality control evalua ...... potent gram-positive activity.
@en
Initial quality control evalua ...... potent gram-positive activity.
@nl
type
label
Initial quality control evalua ...... potent gram-positive activity.
@en
Initial quality control evalua ...... potent gram-positive activity.
@nl
prefLabel
Initial quality control evalua ...... potent gram-positive activity.
@en
Initial quality control evalua ...... potent gram-positive activity.
@nl
P2093
P2860
P1476
Initial quality control evalua ...... potent gram-positive activity.
@en
P2093
Douglas J Biedenbach
Quality Control Working Group
Ronald N Jones
Tamara R Anderegg
P2860
P304
P356
10.1128/JCM.41.6.2795-2796.2003
P407
P577
2003-06-01T00:00:00Z